The US Food and Drug Administration (FDA) has approved a new formulation of the triazole antifungal posaconazole (Noxafil, Merck), the manufacturer announced today. The agency approved posaconazole ...
Posaconazole, a second-generation triazole antifungal agent, has become increasingly significant in the management of invasive fungal infections (IFIs), particularly in immunocompromised and ...
PENSACOLA, Fla., June 12, 2025 /PRNewswire/ -- Pegasus Laboratories/PRN Pharmacal has announced the addition of a new FDA conditionally approved drug, Felycin ®-CA1 (sirolimus delayed-release tablets) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results